Geode Capital Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-343,668
| Closed | -$23.3M | – | 4279 |
|
|
2019
Q3 | $23.3M | Sell |
343,668
-3,526
| -1% | -$242K | 0.01% | 1378 |
|
|
2019
Q2 | $20.2M | Sell |
347,194
-43,570
| -11% | -$2.58M | ﹤0.01% | 1476 |
|
|
2019
Q1 | $27.4M | Buy |
390,764
+66,236
| +20% | +$4.91M | 0.01% | 1207 |
|
|
2018
Q4 | $20.9M | Buy |
324,528
+60,616
| +23% | +$4.25M | 0.01% | 1244 |
|
|
2018
Q3 | $18.5M | Buy |
263,912
+8,944
| +4% | +$523K | 0.01% | 1469 |
|
|
2018
Q2 | $12.8M | Buy |
254,968
+19,730
| +8% | +$783K | ﹤0.01% | 1679 |
|
|
2018
Q1 | $7.36M | Buy |
235,238
+55,773
| +31% | +$1.85M | ﹤0.01% | 1991 |
|
|
2017
Q4 | $6.14M | Sell |
179,465
-31,536
| -15% | -$1.01M | ﹤0.01% | 2095 |
|
|
2017
Q3 | $6.77M | Buy |
211,001
+5,288
| +3% | +$167K | ﹤0.01% | 2015 |
|
|
2017
Q2 | $6.7M | Sell |
205,713
-125
| -0.1% | -$3.96K | ﹤0.01% | 1946 |
|
|
2017
Q1 | $6.48M | Buy |
205,838
+13,549
| +7% | +$401K | ﹤0.01% | 1926 |
|
|
2016
Q4 | $5.65M | Buy |
192,289
+26,852
| +16% | +$819K | ﹤0.01% | 1986 |
|
|
2016
Q3 | $4.78M | Buy |
165,437
+3,598
| +2% | +$100K | ﹤0.01% | 2003 |
|
|
2016
Q2 | $4.19M | Buy |
161,839
+3,761
| +2% | +$99.9K | ﹤0.01% | 2034 |
|
|
2016
Q1 | $3.92K | Buy |
158,078
+18,645
| +13% | +$512K | ﹤0.01% | 2029 |
|
|
2015
Q4 | $4.91M | Sell |
139,433
-5,119
| -4% | -$137K | ﹤0.01% | 1892 |
|
|
2015
Q3 | $3.06M | Buy |
144,552
+2,995
| +2% | +$77.2K | ﹤0.01% | 2160 |
|
|
2015
Q2 | $3.93M | Buy |
141,557
+33,438
| +31% | +$943K | ﹤0.01% | 2076 |
|
|
2015
Q1 | $3.3M | Buy |
108,119
+3,542
| +3% | +$113K | ﹤0.01% | 2112 |
|
|
2014
Q4 | $3.34M | Buy |
104,577
+7,065
| +7% | +$230K | ﹤0.01% | 2074 |
|
|
2014
Q3 | $2.76M | Buy |
97,512
+1,270
| +1% | +$35.4K | ﹤0.01% | 2167 |
|
|
2014
Q2 | $2.64M | Buy |
96,242
+1,516
| +2% | +$40.4K | ﹤0.01% | 2201 |
|
|
2014
Q1 | $2.5M | Buy |
94,726
+3,068
| +3% | +$88K | ﹤0.01% | 2208 |
|
|
2013
Q4 | $2.68M | Buy |
91,658
+8,561
| +10% | +$272K | ﹤0.01% | 2113 |
|
|
2013
Q3 | $2.54M | Buy |
83,097
+2,216
| +3% | +$74.1K | ﹤0.01% | 2028 |
|
|
2013
Q2 | $2.56M | Buy |
+80,881
| New | +$2.66M | ﹤0.01% | 1878 |
|
Geode Capital Management's GHDX Position: Q4 2019 in Review
Geode Capital Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 343,668 shares — an estimated $23.3M sold.
Geode Capital Management first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $27.4M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Geode Capital Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Geode Capital Management sold 343,668 Genomic Health, Inc. shares in Q4 2019, an estimated $23.3M.
- Geode Capital Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Geode Capital Management's Genomic Health, Inc. position peaked at $27.4M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.